Similar Items: Heterogeneous responses to memantine in Alzheimer's disease: A precision medicine approach using iPSC models
- Heterogeneous trajectories of executive function in clinical Alzheimer's disease: Results from the 3C study
- Alzheimer's disease drug development pipeline: 2026
- Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease
- Interchangeability of CSF and PET to identify Alzheimer's disease pathology
- Heritability of Alzheimer's disease–related plasma biomarkers in the Amish population
- Features predicting data exclusion in imaging studies of Alzheimer's disease